Categories: CoronavirusWorld News

Japan Approves Remdesivir For COVID-19 Treatment

Japan’s Prime Minister Shinzo Abe speaks during a press conference at the prime minister’s official residence in Tokyo on April 17, 2020. AFP.

 

Japan on Thursday authorised the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.

This makes Japan the second country to approve the drug after US regulators authorised it on Friday for emergency use against severe cases of COVID-19.

“Remdesivir was approved under exceptional measures,” a health, labour and welfare ministry official said.

“It was our country’s first such approval for the treatment of coronavirus patients,” the official told AFP.

Prime Minister Shinzo Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by US firm Gilead Sciences.

The US go-ahead came after a major clinical trial showed remdesivir — originally developed to treat Ebola — shortened the time to recovery in some patients by a third.

The difference in mortality rate was not statistically significant.

Remdesivir, which is administered by injection, was already available to some patients who enrolled in clinical trials around the world.

READ ALSO: Japan Set To Approve Remdesivir For COVID-19 Treatment

As for Avigan, developed by Japanese firm Fujifilm Toyama Chemical, top government spokesman Yoshihide Suga said the government “aims to approve it this month” if a clinical trial involving 100 patients proves effective.

The drug, whose generic name is favipiravir, was approved for use in Japan in 2014 but only in flu outbreaks that are not being effectively addressed by existing medications.

It is not available on the market and can only be manufactured and distributed at the request of the Japanese government.

Favipiravir, which can be taken orally as a pill, works by blocking the ability of a virus to replicate inside a cell.

Remdesivir incorporates itself into the virus’s genome, short-circuiting its replication process.

Avigan has been shown in animal studies to affect fetal development, meaning it is not given to pregnant women.

AFP

Anthonia Orji

Disqus Comments Loading...
Share
Published by
Anthonia Orji

Recent Posts

With Dangote Refinery, Diesel Prices Will Fall Below N1,000 By May — Rewane

"Fiscal measures will complement monetary control tools and diesel prices will fall further below 1000…

5 hours ago

Dyche Believes In Everton’s Survival Bid After Bournemouth Blow

Everton sit just three points above the relegation zone with nine games left in their…

5 hours ago

Lizzo Says ‘I Quit’ After ‘Lies’ Told About Her

"I'm getting tired of putting up with being dragged by everyone in my life and…

7 hours ago

I Inherited $587m, N85bn Debt From El-Rufai’s Govt — Gov Sani 

The governor said he remained resolute in steering Kaduna to the path of progress using…

7 hours ago

Son Sends Tottenham Into Top Four, More Pain For Pochettino’s Chelsea

Spurs have now come from behind to win in four of their last five home…

7 hours ago

How Attending To Customers In My Grandma’s Store Exposed Me To Business — Awosika

The Founder of The Chair Centre Group and former Chairperson of First Bank of Nigeria…

8 hours ago